ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
11 Sep 2020

Acarix offentliggör slutgiltigt utfall i övertecknad företrädesemission

Pressmeddelande Malmö, Sverige, 11 september 2020 Acarix offentliggör slutgiltigt utfall i övertecknad företrädesemissionAcarix AB (&#...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Sep 2020

Acarix offentliggör preliminärt utfall i övertecknad företrädesemission

Pressmeddelande Malmö, Sverige, 9 september 2020 Acarix offentliggör preliminärt utfall i övertecknad företrädesemission INSIDERINFOR...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Sep 2020

Acarix announces preliminary outcome in oversubscribed rights issue

Press release Malmö, Sweden September 9, 2020 Acarix announces preliminary outcome in oversubscribed rights issue INSIDE INFORMATION:...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Sep 2020

Acarix publishes a supplement to the prospectus

  Press releaseMalmö, Sweden September 3, 2020 Acarix publishes a supplement to the prospectus The board of directors of Acarix AB (...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Aug 2020

Acarix offentliggör prospekt i samband med företrädesemission om cirka 56 MSEK

Acarix offentliggör prospekt  i samband med företrädesemission om cirka 56 MSEK Extra bolagsstämma i Acarix AB ("Acarix" ell...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Aug 2020

Acarix publishes prospectus in connection with rights issue of approximately SEK 56 million

Acarix publishes prospectus in connection with rights issue of approximately SEK 56 million The Extraordinary General Meeting o...
Continue reading
author-avatar acarix
Press
August 6, 2024
07 Aug 2020

Acarix AB (publ) publicerar delårsrapport, januari – juni 2020

Press release (MAR) Malmö, 7 augusti, 2020 Acarix AB (publ) publicerar delårsrapport, januari – juni 2020 Adaptiva och f...
Continue reading
author-avatar acarix
Press
August 6, 2024
07 Aug 2020

Acarix AB (publ) publishes Interim Report, January – June 2020

Press release (MAR) Malmö, August 7, 2020 Acarix AB (publ) publishes Interim Report, January – June 2020 Agile and flexible wit...
Continue reading
author-avatar acarix
Press
August 6, 2024
15 Jul 2020

Acarix decides on a guaranteed rights issue of approximately SEK 56 million

Press release Malmö, Sweden July 15, 2020 Acarix decides on a guaranteed rights issue of approximately SEK 56 million The board of di...
Continue reading
author-avatar acarix
Press
August 6, 2024
15 Jul 2020

Acarix beslutar om garanterad företrädesemission om cirka 56 MSEK

Pressmeddelande Malmö, Sverige, 15 juli 2020 Acarix beslutar om garanterad företrädesemission om cirka 56 MSEK Styrelsen i Acarix AB ...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 May 2020

Acarix AB (publ) publicerar delårsrapport, januari – mars 2020

Press release (MAR) Malmö, 14 maj, 2020 Acarix AB (publ) publicerar delårsrapport, januari – mars 2020 Fortsatt fokus på strategiska...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 May 2020

Acarix AB (publ) publishes Interim Report, January – March 2020

Press release (MAR) Malmö, May 14, 2020 Acarix AB (publ) publishes Interim Report, January – March 2020 Continued focus on strategic ...
Continue reading
  • «
  • ‹
  • 11
  • 12
  • 13
  • 14
  • 15
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.